Skip to main content
. 2015 Aug;56(4):351–356. doi: 10.3325/cmj.2015.56.351

Figure 1.

Figure 1

Cumulative major adverse cardiovascular events (MACE) free survival according to: (A) baseline high sensitivity C-reactive protein (hsCRP), (B) estimated glomerular filtration rate (eGFR), and (C) combined effect of baseline hsCRP and eGFR in 319 patients with symptomatic peripheral artery disease.